EUVIMEDEUVIMED entdecken
Crossref

PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis

Mohamed Zaza, Mohammed H Rashed, Hesham Elrefaey, Memy H Hassan iD, Osama M Abo-Salem, El-Sayed M El-Sayed

Canadian Journal of Physiology and Pharmacology · 2024

DOI: 10.1139/cjpp-2023-0031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2024. Verfasst von Mohamed Zaza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxic1ology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: Tumor Suppressor Protein p53, Triple Negative Breast Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study concerned with assessing the effect of restoring p53 using PRIMA-1 on the anti-cancer activity of olaparib against TP53-mutant triple negative breast cancer (TNBC) cells and exploring the optimum synergistic concentrations and the underlying mechanism. Human BC cell lines, MDA-MB-231 with mutated TP53 gene, and MCF-7 with wild-type TP53 gene were treated with olaparib and/or PRIMA-1. The IC 50 value for olaparib was significantly decreased by PRIMA-1 in MDA-MB-231 cells compared to MCF-7 cells. Contrary to MCF-7 cells, co-treatment with olaparib and PRIMA-1 had a synergistic anti-proliferative effect in MDA-MB-231 at all tested concentrations with the best synergistic combination at 45 and 8.5 µM, respectively, and furthermore PRIMA-1 enhanced olaparib-induced apoptosis. This synergistic apoptotic effect was associated with a significant boost in mRNA expression of TP53 gene, cell cycle arrest at G2/M phase, modulation of BRCA-1, BAX and Bcl2 proteins expressions, and induction of active caspase-3. These results present a clue for the utility of combined olaparib and PRIMA-1 in treatment of TP53-mutant TNBC invitro. PRIMA-1 triggers olaparib-induced MDA-MB-231 cell death in a synergistic manner via restoring TP53, decreasing BRCA-1 expression, cell cycle arrest, and enhancement of apoptosis via p53/BAX/Bcl2/caspase 3 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Suppressor Protein p53Triple Negative Breast NeoplasmsHumansGenes, p53bcl-2-Associated X ProteinCell Line, TumorApoptosisCell DeathCell DivisionCell CycleCell ProliferationAza CompoundsBridged Bicyclo Compounds, HeterocyclicPhthalazinesPiperazines

Stichwörter der Autor:innen

PARP inhibitorPRIMA-1apoptosisolaparibtriple negative breast cancer

Substanzen

Tumor Suppressor Protein p53bcl-2-Associated X Protein2,2-bis(hydroxymethyl)-1-azabicyclo(2,2,2,)octan-3-oneAza CompoundsBridged Bicyclo Compounds, HeterocyclicolaparibPhthalazinesPiperazines

Autor:innen und Institutionen

  • Department of Pharmacology and Toxic1ology, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.
  • Children's Cancer Hospital Egypt (CCHE 57357), Cairo, Egypt.

ORCID-Profile: Memy H Hassan

Zitieren

APA

Zaza, M., Rashed, M. H., Elrefaey, H., Hassan, M. H., Abo-Salem, O. M., & El-Sayed, E. S. M. (2024). PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2023-0031

Vancouver

Zaza M, Rashed MH, Elrefaey H, Hassan MH, Abo-Salem OM, El-Sayed ESM. PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis. Canadian Journal of Physiology and Pharmacology. 2024. doi:10.1139/cjpp-2023-0031

BibTeX
@article{Zaza2024,
  author = {Zaza, Mohamed and Rashed, Mohammed H and Elrefaey, Hesham and Hassan, Memy H and Abo-Salem, Osama M and El-Sayed, El-Sayed M},
  title = {PRIMA-1 synergizes olaparib-induced cell death in p53 mutant triple negative human breast cancer cell line via restoring p53 function, arresting cell cycle, and inducing apoptosis},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2024},
  doi = {10.1139/cjpp-2023-0031}
}
Kostenlos starten →